Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical.

Slides:



Advertisements
Similar presentations
Introduction to Drug Information Services Ch.#1. An introductory course to teach the students basic principles of DI retrieval. Designed to help students.
Advertisements

Chronic Medication Service (CMS). Programme Introduction Pharmaceutical Care Planning - Ray ePharmacy Programme – Dawn, IM & T Workshops – Niall, Michelle,
Adherence Ensuring Better Patient Outcomes Lecture # 2 Ghadah Asaad Assiri,MSc May 2014.
Study Design 121 Relapsing-remitting MS patients randomized to –Stress Management Therapy MS active treatment* 16 individual sessions conducted over 24.
Implementing Evidence- Based Practice Training in a Scientist-Practitioner Program David DiLillo Director of Clinical Training University of Nebraska-Lincoln.
Disease State Management The Pharmacist’s Role
The Value of Medication Therapy Management Services
What is going on with psychotherapy today? Carolyn R. Fallahi, Ph. D.
Public Health Impact Basic Science Discovery Translational Research Continuum Proposed Human Application Proven Clinical Application (clinical trials)
Role of Pharmacoeconomics in a Developing country context Gavin Steel for Anban Pillay Cluster Manager: Health Economics National Department of Health.
Measuring Rehabilitation Outcomes. 2 Objectives 1.Describe the importance and benefits of using classification schemes and outcome measures to evaluate.
Clare A Mackie Centre for Partnerships in Medicines for Health Economic Evaluation of a RCT of a ‘Medication Review Clinic’ in Patients Receiving Repeat.
1. 2 Implementing and Evaluating of an Evidence Based Nursing into Practice Prepared By Dr. Nahed Said El nagger Assistant Professor of Nursing H.
Clinical Pharmacy Basma Y. Kentab MSc..
Educational Research Funding Opportunities W. Eryn Perry.
Linda D Urden, DNSc, RN, CNS, NE-BC, FAAN Professor and Director Master’s and International Nursing Programs Hahn School of Nursing and Health Science.
Disease Management: High Risk Groups Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Primary Care Psychology Lisa K. Kearney, Ph.D. Primary Care Psychologist South Texas Veterans Health Care System.
Progress with the literature reviews for the CHOICE programme Chris Dickens.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 18 Mixed Methods and Other Special Types of Research.
The Value of Medication Therapy Management Services.
ISPOR POLAND CHAPTER Polish Society of Pharmacoeconomics (PTFe )
Clinical Pharmacy Part 2
Testing, Piloting and Evaluating RiskMAP Interventions Annette Stemhagen, DrPH, FISPE Vice President, Strategic Development Services.
The Doctor of Nursing Practice Experience Melanie Hardin-Pierce, RN, MSN, APRN-BC.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
Academy of Managed Care Pharmacy P4 student perspective Jina Park The Ohio State University PharmD Candidate 2014
Jonathan H. Watanabe, PharmD, MS, PhD Research Interests Analysis of health services use and costs for patients without access to medications (applying.
TAP PHARMACEUTICAL PRODUCTS INC. June 2, Arthritis Drugs Advisory Committee TAP Pharmaceutical Products Inc. June 2, 2004.
Renu Singh, Pharm.D., BCACP, CDE Research Interests Diabetes Self-Management Clinic Evaluating outcomes in this practice Pts seen, visits, telephone follow-ups.
Lung-2015 Baltimore, USA July , 2015 Suhaj A.
R-7 Health Navigator Initiative Megan O’Brien, PhD, MPH Dot Nary, PhD Sasha Li.
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) PI: Jan Hirsch, RPh, PhD Carol M. Mangione, MD, MSPH Barbara A. Levey.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
Payment and Delivery Reform Virginia Health Care Conference June 6, 2013.
David Adler Research Interests Pharmaceutics Solubility - Phenytoin in IV Solutions Bioavailability/Clinical Equivalence - Sodium Warfarin - RCT Clinical.
Student Learning Outcomes (Pharmacy) Susan S. S. Ho School of Pharmacy Faculty of Medicine The Chinese University of Hong Kong 9 September 2007.
Developing a Survey to Assess Factors that Contribute to Physician Involvement in Clinical Research V Taliercio, J Logan, J Kalpathy-Cramer, P Otero Presented.
Charles E. Daniels, BS Pharm., Ph.D. Research Interests Medication use and outcomes quality Medication distribution technology application Multihospital.
Rabia Atayee Research Interests Opioid therapy Neuropathic pain and adjuvant therapy for pain Role of palliative care in the healthcare setting Teaching.
SimpsonView Graph # 1 OUTLINE What States Are Doing Now What Is Available Now Mechanisms to Influence Quality Choosing a Strategy What Should Be Available.
Value of Pharmacy Services January 31 st (A), 2011 J. Hirsch, Ph.D. SSPPS – 207 Introduction to Health Care Systems and Policy.
The Maryland P 3 (Patients Pharmacists Partnerships) Program TM A cost effective solution to patient-centered health education, medication adherence, and.
Presentation Developed for the Academy of Managed Care Pharmacy
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Katharina Brandl Pharmacology, Educational Research Major instructional goals: Help students master new knowledge and skills Help students to not forget.
Adapted from “Expected Attributes of Entering Pharmacy Students” PHARM. D. PROGRAM – Auburn University. Harrison School of Pharmacy Alabama U.S.A.
1.05 Effective Healthcare Teams
Significance or impacts of proposed research
IPHA Switch-on to Self-Care From Primary Care to Self-Care
Presentation Developed for the Academy of Managed Care Pharmacy
Lecture 15 Assoc. Prof. Sencer Ecer HEALTH ECONOMICS
1.05 Effective Healthcare Teams
On November 10th, Cardinal Health’s Women in Pharmacy Oklahoma Chapter partnered with SWOSU COP’s Rural Health Network to present a free Medication Therapy.
Quality of Life Assessment
Amy L. Ai, PhD College of Social Work (Pepper Institute Associate; Psychology, Nursing, and Behavioral Science Adjuncts)
Nursing-Sensitive Quality Indicators And Safety Initiatives
Acute Heart Failure.
مدل زنجیره ای در برنامه های سلامت
Victoria Gemmell1 Professor Alex Mullen2
Evidence-based Medicine Curriculum
Quality Criteria for Cultural Competence Trainings
Behavioral Sciences and Social Medicine
1.05 Effective Healthcare Teams
ICARE Trial Survey Post-Analysis
Dunleavy G1, Posadzki PP1, Kyaw BM2, Car J 1, 3.
1.05 Effective Healthcare Teams
1.05 Effective Healthcare Teams
Andrew Merron Executive Director, Oncology & Biosimilars
1.05 Effective Healthcare Teams
Presentation transcript:

Jan D. Hirsch, BS Pharm, PhD Research Interests Pharmacoeconomics & Outcomes Research “Value” of Pharmacist Services & Pharmaceuticals - Economic, clinical and humanistic outcomes - Diabetes, hypertension, gout, mental health, HIV/AIDS, gout… - Novel pharmacy practice models Health Related Quality of Life (HRQOL) - Develop and assess instruments for clinical trials and practice - Gout Impact Scale (GIS) in multinational clinical trials for new therapies - Student Quality of Life, Stress, & Coping Skills

Core Expertise Assessing Patient Reported Outcomes (PROs) - Patient/subject perceptions, attitudes, knowledge, intentions, symptoms - Health Related Quality of Life (HRQOL) Instrument development and validation Assessment across patient groups, countries, cultures Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions Pre-market “value” of new pharmaceuticals - Economic, clinical and humanistic value propositions - Given current and likely future market conditions - Evidence required for reimbursement by payers all countries - Pharmacoeconomic research strategy and plan to collect and disseminate needed data

Proposed Collaborations with SSPPS Faculty Assessing Patient Reported Outcomes (PROs) - Patient/subject perceptions, attitudes, knowledge, intentions, symptoms - Health Related Quality of Life (HRQOL) Instrument development and validation Assessment across patient groups, countries, cultures Assessing outcomes (ECHO) in patient populations - identify patients likely to benefit most from new intervention (best value) - change in outcomes due to new vs. usual care interventions Pre-market “value” of new pharmaceuticals - Economic, clinical and humanistic value propositions - Given current and likely future market conditions - Evidence required for reimbursement by payers all countries - Pharmacoeconomic research strategy and plan to collect and disseminate needed data Clinical Faculty Pharm Sciences